AITRICS, a Korea-based startup offering AI
solutions which was founded in 2016, has signed a joint research agreement with
Cleveland Clinic, a private, non-profit hospital health system based in
Cleveland, Ohio. Both parties will collaborate on verifying VitalCare,
AITRICS's AI platform that predicts critical events in hospitals.
WHY IT MATTERS
Sepsis is a disease that causes a systemic
inflammatory response after infection from microbes, which has a high mortality
rate to be selected as the leading cause of death globally. Early detection is
the best because there is no underlying cure for sepsis. If sepsis treated
within 1 hour after onset, the survival rate is 80%, but after 6 hours, it
falls to 30%.
The challenge is that diagnosis can be
tricky or misleading as the symptoms are too generic. To detect sepsis, doctors
need to determine whether patients have an infection, but the results of the
blood test will take at least two days, which is too late for intervention.
WHAT’S IT ABOUT
Both parties will start off by verifying
the AI solution platform, VitalCare, an AI-based platform that significantly
reduces the mortality rate of patients by timely detecting the occurrence of
risk factors in a hospital through real-time monitoring of the patient's EMR.
AITRICS verifies the accuracy of VitalCare and advances its AI model by
utilizing datasets provided by Cleveland Clinic.
The two parties aim to cope better with
patients during golden hour (the period of time following a traumatic injury
during which there is the highest likelihood that prompt medical and surgical
treatment will prevent death) and optimize resource management in hospitals
through the solution.
FUTURE PLANS
AITRICS says it plans to expand VitalCare's
predicted types of diseases and modality sequentially by verifying its AI
models based on clinical data from the Cleveland Clinic. Also, the startup is
expected to develop an AI model that takes into account various factors to
build a solution for predicting severe deaths that is applicable to patients in
multiple countries through collaborations with overseas hospitals.
THE LARGER TREND
Cleveland Clinic is establishing a research
arm that will use data from multiple sources, including its EHR, to study
emerging pathogens, HealthCare IT News reported. The Center for Global and
Emerging Pathogens Research, which has been in the works for the past 1.5
years, will mine various data sources and then develop tools that can be used
to predict risk and outcomes in patients.
ON THE RECORD
“In collaboration with
Cleveland Clinic, one of the best hospitals in the United States, we have made
a successful first in applying AI to clinical practice to create real value,”
said Jinkyu Yoo, CEO and Co-founder of AITRICS. “It has been possible to
improve the accuracy of VitalCare by verifying with top tier Hospitals in the
US. Through this, we confirmed the possibility of medical AI solutions. We will
expand to other fields based on certified technology to solve the problems
prevalent in all parts of society.”
